@swog.org #S2200 is also still accruing!! An important trial since there are so few for #papillaryRCC. Also happy to chat w/ patients considering this for metastatic #papillarykidneycancer. In this limited non-clear cell space, patients deserve more trials like this! #SWOGFall2025